BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL

被引：0
|
作者：
Medina Pestana, J. [1 ]
Grinyo, J. [2 ]
Vanrenterghem, Y. [3 ]
Becker, T. [4 ]
Florman, S. [5 ]
Lang, P. [6 ]
Rial, M. del C. [7 ]
Schnitzler, M. [8 ]
Duan, T. [9 ]
Block, A. [9 ]
Durrbach, A. [10 ]
机构：
[1] Hosp Rim & Hipertensao, Sao Paulo, Brazil
[2] Univ Hosp Bellvitge, Barcelona, Spain
[3] Univ Hosp Leuven, Louvain, Belgium
[4] Hannover Med Sch, D-30623 Hannover, Germany
[5] Mt Sinai Med Ctr, New York, NY 10029 USA
[6] Hop Henri Mondor, F-94010 Creteil, France
[7] Inst Nefrol, Buenos Aires, DF, Argentina
[8] St Louis Univ, St Louis, MO 63103 USA
[9] Bristol Myers Squibb Co, Princeton, NJ USA
[10] Hop Bicetre, Le Kremlin Bicetre, France
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] BELATACEPT IS ASSOCIATED WITH PRESERVATION OF RENAL FUNCTION AND STRUCTURE AT 1 YEAR COMPARED TO CYCLOSPORINE IN EXTENDED CRITERIA DONOR (ECD) KIDNEY TRANSPLANT PATIENTS (BENEFIT-EXT STUDY)
    Medina-Pestana, J. D.
    Campistol, J. M.
    Rial, M. del C.
    Garcia, V. D.
    Becker, T.
    Agarwal, M.
    Garg, P.
    Duan, T.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 89 - 89
  • [22] Primary Outcomes from a Randomized, Phase III Study of Belatacept Versus Cyclosporine in ECD Kidney Transplants (BENEFIT-EXT Study)
    Durrbach, Antoine
    Florman, Sander
    Larsen, Christian
    Pestana, Jose Medina
    Vanrenterghem, Yves
    Vincente, Flavio
    Block, Alan
    Garg, Pushkal
    Grinyo, Josep
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 7 - 7
  • [23] PRIMARY OUTCOMES FROM A RANDOMIZED, PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS (BENEFIT-EXT STUDY)
    Durrbach, A.
    Larsen, C.
    Medina-Pestana, J. D.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Block, A. J.
    Garg, P.
    Sen, K.
    Grinyo, J. M.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 89 - 89
  • [24] Primary Outcomes from a Randomized, Phase III Study of Belatacept vs Cyclosporine in ECD Kidney Transplants (BENEFIT-EXT Study).
    Durrbach, A.
    Larsen, C.
    Medina-Pestana, J. D.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Block, A. J.
    Garg, P.
    Sen, K.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 199 - 199
  • [25] Likelihood of Improving or Maintaining Renal Function in Recipients of Extended-Criteria Donor Kidneys over Five Years with Belatacept or CsA (BENEFIT-EXT Long-Term Extension Study)
    Grinyo, J.
    Vanrenterghem, Y.
    Durrbach, A.
    Rial, M.
    Charpentier, B.
    Matas, A.
    Lehner, F.
    Pupim, L.
    Coffey, M.
    Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 310 - 310
  • [26] Three-Year Outcomes in Patients with Delayed Graft Function in Phase III Studies of Belatacept Vs Cyclosporine in Kidney Transplantation (BENEFIT and BENEFIT-EXT)
    Charpentier, B.
    Vincenti, F.
    Rice, K.
    Budde, K.
    Campistol, J.
    Duan, T.
    Pupim, L.
    Florman, S.
    TRANSPLANTATION, 2012, 94 (10) : 996 - 996
  • [27] Belatacept vs Cyclosporine in ECD Kidney Transplants: Two-Year Outcomes from the BENEFIT-EXT Study
    Durrbach, A.
    Larsen, C. P.
    Pestana, J. Medina
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 83 - 83
  • [28] RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES
    Durrbach, Antoine
    Citterio, Franco
    Mulloy, Laura
    David-Neto, Elias
    Russ, Graeme
    Vitko, Sefan
    Zhang, Rubin
    Xing, Jun
    Harler, Mary Beth
    Grinyo, Josep
    TRANSPLANT INTERNATIONAL, 2011, 24 : 249 - 249
  • [29] BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS: TWO-YEAR OUTCOMES FROM THE BENEFIT-EXT STUDY
    Durrbach, A.
    Larsen, C.
    Medina Pestana, J.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 59 - 59
  • [30] Renal Function in Patients Treated with Belatacept- or Cyclosporine-Based Regimens at Year 3 in the BENEFIT and BENEFIT-EXT Studies
    Durrbach, A.
    Citterio, F.
    Mulloy, L.
    David-Neto, E.
    Russ, G.
    Vitko, S.
    Zhang, R.
    Xing, J.
    Harler, M. B.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 100 - 100
12345